December 20, 2022
C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System: C-Path announced that its Transplant Therapeutics Consortium (TTC) received a qualification opinion for the iBox Scoring System as a secondary efficacy endpoint in clinical trials investigating novel immunosuppressive medicines in kidney transplant patients.
